The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...
Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relationsAdvanced mu ...
Dyadic International Inc. ( ($DYAI) ) has released its Q3 earnings. Here is a breakdown of the information Dyadic International Inc. presented to ...
Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned ...
AgroNetica, a leader in applying CRISPR technology for cacao, today unveils its revolutionary "super-cacao" project. While other companies focus on solving individual problems in Chocolate, AgroNetica ...
The company scans entire proteins with CRISPR to find functional vulnerabilities, then hunts for molecules that exploit them ...
Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...
Advances in genome editing have transformed the development of animal models used to understand human diseases. While transgenic mouse models have broadly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback